当前位置: 首页 > 期刊 > 《中国医药导报》 > 2015年第28期
编号:1599571
骨髓间充质干细胞治疗肺部疾病的现状研究
http://www.100md.com 2015年10月28日 中国医药导报 2015年第28期
慢性阻塞性肺疾病
     所鸿 孙嘉琳 董京生

    [摘要] 骨髓间充质干细胞(BMSCs)是具有自我复制和多向分化潜能的原始细胞,可分化为三个胚层来源的细胞系,发育成不同的组织细胞。近年来,随着人们对BMSCs生物学特性、体外分离纯化及培养认识的不断深入,以BMSCs为实验载体,利用其增殖及归巢特性,对慢性阻塞性肺疾病的根本性逆转治疗以及其对肺部肿瘤的抑制及治疗等方面有新的观点和研究方向。文本就近年来该方面相关研究进展进行综述。

    [关键词] 骨髓间充质干细胞;肺部;慢性阻塞性肺疾病;肿瘤

    [中图分类号] R563 [文献标识码] A [文章编号] 1673-7210(2015)10(a)-0029-04

    Current situation research of potential bone marrow mesenchymal stem cells therapy for pulmonary diseases

    SUO Hong SUN Jialin DONG Jingsheng

    Department of Respiratory, Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia Autonomous Region, Huhhot 010059, China

    [Abstract] Bone marrow mesenchymal stem cells (BMSCs) are primitive cells with self-replication and multi-directional differentiation potential, which can differentiate into three layer source cell line, develop into different tissue cells. In recent years, along with the deeply understand of its biological characteristics, purification and culture in vitro, taking BMSCs as experimental carrier, using its proliferation and homing feature, there has new ideas and research direction in the aspects of a fundamental reversal treatment for chronic obstructive pulmonary disease and its inhibition and treatment for lung tumor. This article reviews its research progress. ......

您现在查看是摘要页,全文长 13531 字符